GENEVA, Sept. 7 -- RHYTHM PHARMACEUTICALS, INC. filed a patent application (US2025/053408) for “COMBINATIONS OF G-PROTEIN COUPLED HORMONE RECEPTOR MODULATORS AND MELANOCORTIN 4 RECEPTOR AGONISTS AND RELATED METHODS OF USE”. With publication no. WO/2026/096813, here are the other details related to the patent application:
Kind: Later publication of international search report [A3]
IPC: A61K 31/5377
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....